{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:08:27Z","timestamp":1789549707926,"version":"build-2803163510"},"reference-count":52,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2023,9,2]]},"DOI":"10.1080\/1744666x.2023.2219897","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:35:27Z","timestamp":1685187327000},"page":"1053-1062","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Topical roflumilast for the treatment of psoriasis"],"prefix":"10.1080","volume":"19","author":[{"given":"Anastasia","family":"Drakos","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-2724","authenticated-orcid":false,"given":"Ron","family":"Vender","sequence":"additional","affiliation":[{"name":"Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, ON, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-0870","authenticated-orcid":false,"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, University of Porto, Porto, Portugal"},{"name":"Department of Dermatology, Centro Hospitalar de Santo Ant\u00f3nio, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.743180"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1746734"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1729335"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.087"},{"issue":"2","key":"cit0006","first-page":"ii83","volume":"64","author":"Lebwohl M","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00649-w"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.2174\/1574886315666200128095958"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15931"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103629"},{"key":"cit0011","unstructured":"US Food and Drug Administration. Full prescribing information: zORVYE (roflumilast) cream, for topical use. Published 2022. Accessed Jan 15, 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215985s000lbl"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2010.03.011"},{"key":"cit0013","unstructured":"Arcutis Biotherapeutics, Inc. Open-label extension trial of PDE4 inhibition with roflumilast for the management of plaque psoriasis (DERMIS-OLE) NCT04286607. Available from: Accessed Mar 21, 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04286607?cond=Roflumilast+AND+psoriasis&draw=2&rank=7"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01048"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S303634"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14139"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-013-0023-0"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15727"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.001"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.07.040"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0302-0"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.1288"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420909794"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.06.044"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.232819"},{"key":"cit0026","volume-title":"Daliresp (roflumilast) prescribing information","author":"AstraZeneca Pharmaceuticals LP","year":"2020"},{"key":"cit0027","unstructured":"Arcutis Biotherapeutics, Inc. Arcutis announces positive topline results from second atopic dermatitis pivotal phase 3 trial of roflumilast cream in adults and children aged 6 and older [internet]. 2022. Available from: https:\/\/www.arcutis.com\/arcutis-announces-positive-topline-results-from-second-atopic-dermatitis-pivotal-phase-3-trial-of-roflumilast-cream-in-adults-and-children-aged-6-and-older\/"},{"key":"cit0028","unstructured":"Arcutis Biotherapeutics, Inc. Arcutis announces positive topline results from INTEGUMENT-1 pivotal phase 3 trial of roflumilast cream in atopic dermatitis in adults and children aged six years and older [Internet]. 2022. [Internet]: Accessed Mar 21, 2023. https:\/\/www.arcutis.com\/arcutis-announces-positive-topline-results-from-integument-1-pivotal-phase-3-trial-of-roflumilast-cream-in-atopic-dermatitis-in-adults-and-children-aged-six-years-and-older\/"},{"key":"cit0029","first-page":"e230846","author":"Zirwas MJ","year":"2023","journal-title":"JAMA Dermatol"},{"key":"cit0030","unstructured":"Arcutis Biotherapeutics, Inc. Arcutis announces positive topline results from ARRECTOR pivotal phase 3 trial of Roflumilast foam 0.3% in scalp and body psoriasis [internet]. 2022. Available from: Accessed Mar 21, 2023. https:\/\/www.arcutis.com\/arcutis-announces-positive-topline-results-from-arrector-pivotal-phase-3-trial-of-roflumilast-foam-0-3-in-scalp-and-body-psoriasis\/"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00741-9"},{"key":"cit0032","first-page":"169","volume":"39","author":"Miselnicky SR","year":"1988","journal-title":"J Soc Cosmet Chem"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.2020.5370"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2000073"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad060"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00739-3"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.25251\/skin.5.supp.44"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.15632"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.753"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.406"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15450"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.7326\/ACPJ202011170-055"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00536-6"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.3390\/life12122050"},{"key":"cit0045","first-page":"760","volume":"16","author":"Khosravi H","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.678"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.14663"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17053"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15104"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.17.05697-8"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18751"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18761"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2023.2219897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T10:16:20Z","timestamp":1692353780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2023.2219897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,2]]}},"alternative-id":["10.1080\/1744666X.2023.2219897"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2023.2219897","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}